SCHEMBL14876578

SCHEMBL14876578

CC[N+](CC)(CC)CCNc1ccc(NCC[N+](CC)(CC)CC)c2c1C(=O)c1c(O)ccc(O)c1C2=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.59
▸ MEN1 O00255 7/20 0.56
▸ KMT2A Q03164 7/20 0.56
▸ MAPK1 P28482 5/20 0.56
▸ BLM P54132 4/20 0.56
▸ TDP1 Q9NUW8 4/20 0.56
▸ USP2 O75604 4/20 0.56
▸ RECQL P46063 4/20 0.56
▸ TP53 P04637 4/20 0.56
▸ SMN1; SMN2 Q16637 4/20 0.56
▸ NPC1 O15118 4/20 0.56
▸ RAB9A P51151 4/20 0.56
▸ CYP3A4 P08684 4/20 0.56
▸ HIF1A Q16665 4/20 0.56
▸ LMNA P02545 3/20 0.56
▸ CSNK2A2 P19784 3/20 0.56
▸ CSNK2B P67870 3/20 0.56
▸ CSNK2A1 P68400 3/20 0.56
▸ CSNK2A3 Q8NEV1 3/20 0.56
▸ MTOR P42345 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14876513 0.86 NSD2 (0.47) CYP19A1MEN1KMT2AMAPK1BLM
SCHEMBL9364305 0.85 NQO1 (0.59) CYP19A1MEN1KMT2AMAPK1BLM
SCHEMBL14876631 0.84 CYP19A1 (0.62) CYP19A1MEN1KMT2AMAPK1BLM
SCHEMBL14399365 0.83 CYP19A1 (0.60) CYP19A1MEN1KMT2AMAPK1BLM
SCHEMBL14882566 0.82 CYP19A1 (0.68) CYP19A1MEN1KMT2AMAPK1BLM
SCHEMBL17207499 0.82 CYP19A1 (0.68) CYP19A1MEN1KMT2AMAPK1BLM
Banoxantrone SCHEMBL29378863 0.82 NQO1 (0.72) CYP19A1MEN1KMT2AMAPK1BLM
Banoxantrone SCHEMBL3676563 0.82 NQO1 (0.72) CYP19A1MEN1KMT2AMAPK1BLM
Banoxantrone SCHEMBL30324147 0.81 NQO1 (0.70) CYP19A1MEN1KMT2AMAPK1BLM
SCHEMBL14876929 0.80 MEN1 (0.55) MEN1KMT2AMAPK1BLMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11255761-B2 Method of analysing a cell or other biological material containing a nucleic acid BIOSTATUS LIMITED (GB) 2022-02-22 — — US disclosed
US-20150268142-A1 METHOD OF ANALYSING A CELL OR OTHER BIOLOGICAL MATERIAL CONTAINING A NUCLEIC ACID BIOSTATUS LIMITED (GB) 2015-09-24 — — US disclosed
US-9051467-B2 Method of analysing a cell or other biological material containing a nucleic acid BIOSTATUS LIMITED (GB) 2015-06-09 — — US disclosed
US-20130101994-A1 Method of Analysing a Cell or Other Biological Material Containing a Nucleic Acid BIOSTATUS LIMITED (GB) 2013-04-25 — — US disclosed
Send feedback